Ticker Symbol: RXDX
Prometheus Biosciences Inc
$36.58 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Currency:
USD
Asset
Type: Common Stock
CIK:0001718852
Company Profile
Prometheus Biosciences, Inc. is a biotechnology company pioneering a precision medicine approach for the discovery, development, and commercialization of novel therapeutic and companion diagnostic products for the treatment and diagnosis of IBD. The company's precision medicine platform, Prometheus360, combines proprietary bioinformatics discovery methods with one of the world's largest gastrointestinal bioinformatics databases to identify novel therapeutic targets and develop therapeutic candidates to engage those targets. Prometheus is headquartered in San Diego, CA.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: N/A
Website: www.prometheusbiosciences.com
CEO: N/A
Tags:
N/A
Pricing
Last Updated: December 31, 1969 07:00 PM EST
Previous Close: -
Change:
$0.18
(
0.09%)
Days Range: $199.92 - $199.92
Beta: -
52wk. High: -
52wk. Low: -
Ytd. Change 0.09%
50 Day Moving Average: -
200 Day Moving Average: -
Shares Outstanding: 47813238
Valuation
Market Cap: 955.9B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A